Abstract. Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive and fatal leukemia of T cells. Interferon regulatory factor (IRF)-5 plays a critical role in the induction of interferon genes in viral infected cells. We examined the specific mechanisms underlying the expression and regulation of IRF-5 in HTLV-1-infected T cells. IRF-5 was constitutively transcribed into three distinct alternatively spliced isoforms (V1, V3 and V4) in HTLV-1-infected T-cell lines but not in uninfected T-cell lines. IRF-5 was also upregulated in HTLV-1-infected T-cell lines at protein level. Nuclear IRF-5 expression was noted in ATL cells present in lymph nodes and skin lesions. IRF-5 mRNA expression was induced following infection of T cells with HTLV-1, and specifically by viral oncoprotein Tax. Tax also activated V3 promoter. Microarray analysis of IRF-5-expressing uninfected T cells demonstrated that IRF-5 induced the expression of tumor necrosis factor family cytokines. The results suggest that IRF-5 is a Tax-regulated gene, and its expression may be associated with the pathogenesis of ATL.
Introduction
Interferon regulatory factor (IRF)-5 is a transcription factor member of the IRF family that regulates the expression of genes induced by viral infection (1) . While IRF-5 was identified as a regulator of type I interferon (IFN) (2) , further studies indicated that IRF-5 plays essential roles in the regulation of genes involved in the stimulation of the immune system, cell growth, apoptosis and oncogenesis (3) (4) (5) (6) . Overexpression of IRF-5 has been associated with autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis (7, 8) . IRF-5 is a direct target of p53 (9) and displays some tumor suppressor properties as it can induce p21, Bak, Bax and caspase-8 genes (6, 10) . Downregulation of IRF-5 by hypermethylation has been reported in hepatocellular carcinoma and gastric cancer (11, 12) . In contrast, IRF-5 is upregulated in thyroid cancer where it contributes to cell proliferation and survival (13) . High-level expression of IRF-5 has been also detected in Hodgkin's lymphoma cells and considered to be crucial for their survival (14) .
Human T-cell leukemia virus type 1 (HTLV-1) causes either adult T-cell leukemia (ATL) or chronic inflammatory disorders, such as HTLV-1-associated myelopathy/tropical spastic paraparesis, uveitis and arthritis (15, 16) . The HTLV-1 genome encodes the transactivator Tax protein that plays essential regulatory roles in HTLV-1 replication and oncogenic transformation of T lymphocytes (17, 18) . Tax modulates the activation of host signaling pathways to mediate cellular transformation and hyperstimulates the immune system (17, 18) . Therefore, viral Tax protein is considered to initiate the ATL-related leukemogenesis process, which subsequently progresses towards the ultimate leukemic stage through additional events occurring in Tax absence. In addition, Tax plays a central role in the pathophysiology of chronic inflammatory disorders (19) .
With regard to the IRF family of transcription factors, several novel putative targets for Tax-mediated gene activation have been identified. IRF-3, a transcription factor critical in innate immunity to viral infection, is constitutively activated in a Tax-dependent manner (20) . On the contrary, oncogenic IRF-4, another member in the IRF family of transcription factors, is overexpressed in lymphocytes of patients with ATL and HTLV-1-transformed T cells (21) (22) (23) (24) (25) . Tax also induces the expression of IRF-4 (21, (25) (26) (27) . However, the expression of IRF-5 and related regulatory mechanisms have not been fully determined in HTLV-1-infected T cells. In this study, we determined the expression level of IRF-5 in HTLV-1-infected T cells. The results showed that IRF-5 expression was induced by Tax and that it regulated the expression of tumor necrosis factor (TNF) family cytokines. The HTLV-1-infected MT-2, MT-4, C5/MJ,  sLb-1, HUT-102, MT-1, TL-OmI and ED-40515(-) T-cell lines,  and the negative control uninfected human leukemia Jurkat,  MOLT-4 and CCRF-CEM T-cell lines, were grown in Roswell  Park Memorial Institute-1640 medium supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. JPx-9 cells are derivatives of Jurkat with Tax gene, which is stably integrated under the control of a metallothionein promoter (28) . To induce Tax expression, JPx-9 cells were cultured in the presence of 20 µM CdCl 2 . The human acute monocytic leukemia cell line, THP-1, was set as a positive control for IRF-5 expression. TY8-3/MT-2 was established from the interleukin (IL)-2-dependent human T-cell line, TY8-3, co-cultured with mitomycin C (MMC)-treated MT-2 cells, and was capable of growth completely independent of IL-2 (29) . Jurkat cells were stimulated with 1,000 U/ml of recombinant human IFN-α for the indicated time intervals.
Materials and methods

Cell culture.
HTLV-1 infection by co-cultivation.
Peripheral blood mononuclear cells (PbMC) from a healthy donor were isolated from the heparinized blood sample by centrifugation over a Ficoll-Paque layer (GE Healthcare bio-sciences Ab, Uppsala, sweden). MT-2 cells were pretreated with 200 µg/ml of MMC for 60 min, pipetted vigorously, and washed three times with phosphate-buffered saline. PbMC and MMC-treated MT-2 cells were co-cultured in the presence of 10 ng/ml of IL-2. The culture medium was half-changed with fresh medium supplemented with IL-2 every 3 days. since MT-2 cells were pretreated extensively with MMC, no discernible MT-2 cells were found.
RT-PCR.
Total RNA was extracted from cells with TRIzol (Invitrogen Life Technologies, Carlsbad, CA, UsA) according to the protocol provided by the manufacturer. The RNA was reverse transcribed into cDNA using a Primescript™ RT-PCR kit (Takara bio Inc., Otsu, Japan). The sequences of the primers for IRF-5, IFN-α, IFN-β, IFN-γ, 2',5'-oligoadenylate synthetase (2-5 As), MxA, TNF-α, lymphotoxin (LT)-β, β-actin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Tax in HTLV-1-infected T cells, and Tax in JPx-9 cells are summarized in Table I (2, (30) (31) (32) (33) (34) (35) (36) .
Protein extraction and immunoblot analysis.
Immunoblot analysis was performed on whole cell lysate, and nuclear and cytoplasmic fractions. Each protein was extracted as previously described (37) (38) (39) , and subjected to sodium dodecyl sulfate-polyacrylamide gels and transferred to polyvinylidene difluoride membranes. The membranes were then probed for IRF-5 (Abnova Corp., Taipei, Taiwan), actin (NeoMarkers Inc., Fremont, CA, UsA), lamin b (santa Cruz biotechnology Inc., santa Cruz, CA, UsA) or Myc-Tag (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Mouse monoclonal antibody to Tax, Lt-4, was previously described (40) . The bands were visualized using enhanced chemiluminescence kit (Amersham biosciences Corp., Piscataway, NJ, UsA).
Immunofluorescence assays. Cells were fixed in 4% paraformaldehyde and permeabilized with Triton x-100. Then, the cells were stained with mouse anti-IRF-5 antibody (Abnova Corp.). For immunofluorescence studies, washed cells were incubated with anti-mouse secondary antibody conjugated with Alexa Fluor 488 (Invitrogen Life Technologies). The nuclei were stained with Hoechst 33342 (Wako Pure Chemical Industries, Ltd.). After final washing, the cells were examined under a Leica DMI6000 microscope (Leica Microsystems, Wetzlar, Germany). Mounted coverslips were viewed through a 63x oil immersion lens (NA1.4) on a Leica TCs confocal system.
Immunohistochemical analysis. The diagnosis of ATL was based on clinical features, hematological findings and the presence of anti-HTLV-1 antibodies in the serum. biopsy samples were taken from the lesional skin and lymph nodes of four patients with ATL. IRF-5 immunohistochemistry was performed using an anti-IRF-5 antibody (Abnova Corp.) after pretreatment of the deparafinized tissue sections with ready-to-use proteinase k (Dako, Carpinteria, CA, UsA). The sections were counterstained with methyl green, hydrated in ethanol, cleaned in xylene, and mounted. The stained cells were examined under a light microscope (Axicoskop 2 Plus) with an Achroplan 40x/0.65 lens (both from Zeiss, Jena, Germany). Images were acquired with an AxioCam MRc camera and AxioVision 4.7 software (Zeiss). A signed consent form was obtained from each tissue donor.
Plasmids. The IRF-5 P-V3 promoter fragment was cloned into the KpnI and XhoI sites of pGL3-basic vector (Promega Corp., Madison, WI, UsA) (30) . Details of the plasmid expressing the HTLV-1 Tax through β-actin promoter were published previously (41) . The coding sequences of IRF-5 were cloned into the pcDNA4/myc-His A vector (Invitrogen Life Technologies).
Transfection and luciferase assay. Jurkat cells were transfected at 5x10 6 cells with the luciferase reporter plasmid, together with 0.5-5 µg of the Tax expression vector by electroporation (250 V, 960 µF). Each transfection included the phRL-Tk plasmid (Promega Corp.) as an internal control for variation in transfection efficiency. After 48 h, transfected cells were collected by centrifugation, washed with phosphate-buffered saline, and lysed in reporter lysis buffer (Promega Corp.). The luciferase activity was determined by the Dual-Luciferase Reporter system (Promega Corp.) using the protocol supplied by the manufacturer.
Microarray analysis. Jurkat cells were transfected with a control pcDNA4/myc-His A vector or IRF-5 expression vector using MicroPorator MP-100 (Digital bio Technology Co., Ltd., seoul, korea), pulsed three times at 1,325 V for 10 msec each. After 24 h, total RNA samples were prepared using the RNeasy Plus Mini kit (Qiagen, Hilden, Germany) and confirmed to be of good quality by Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Waldbronn, Germany). Microarray analysis using a surePrint G3 Human GE 8x60 k Microarray kit version 2.0 (Agilent Technologies, Inc.) was performed as previously described (42) .
Results
Expression of IRF-5 in HTLV-1-infected T-cell lines.
To investigate IRF-5 expression in both HTLV-1-infected and -uninfected T-cell lines, we collected three uninfected (Jurkat, MOLT-4 and CCRF-CEM), five HTLV-1-transformed (MT-2, MT-4, C5/MJ, sLb-1 and HUT-102) and three ATL-derived [MT-1, TL-OmI and ED-40515(-)] T-cell lines. All HTLV-1-transformed T-cell lines constitutively expressed Tax mRNA (Fig. 1A, panel 1) . Expression of IRF-5 mRNA in 11 T-cell lines was analyzed by reverse-transcription polymerase chain reaction (RT-PCR) using IRF-5 specific primers. All eight of the HTLV-1-positive T-cell lines examined (lanes 4-11) strongly expressed IRF-5 mRNA, whereas the three HTLV-1-negative T-cell lines (lanes 1-3) did not (Fig. 1A, panel 2) . IRF-5 is transcribed into various distinct alternatively spliced isoforms (30) , and the IRF-5 variant 1 (V1), V2 and V3 transcripts have different noncoding first exons, whereas V1 and V4 share the same first exon. Primer sets that specifically recognize exon 1 of each isoform (Ex1V1, Ex1V2 and Ex1V3) and a common region in exon 4 of IRF-5 were optimized (Table I) .
PCR amplification using the exon 1-specific sense primers was isoform-specific. We next examined the levels of constitutive exon 1-specific IRF-5 isoform expression in several T-cell lines (Fig. 1A, panels 3-5 ). Ex1V1 transcripts were detected in all HTLV-1-infected T-cell lines (Fig. 1A, panel 3) . In comparison, transcripts associated with Ex1V2 could not be detected (Fig. 1A, panel 4) . IRF-5 V3 transcript levels were specifically high in Tax Fig. 1A, panel 7, lanes 4-9) . Intracellular mapping by immunoblotting and immunofluorescence staining showed high levels of IRF-5 in the nuclei of HTLV-1-infected HUT-102 cells (Fig. 1b and C) . In contrast, almost no IRF-5 was detected in uninfected Jurkat cells (Fig. 1C) .
Abundant IRF-5 expression in ATL cells in lymph nodes and skin lesions.
Immunohistochemical staining of ATL cells in archived lymph nodes and skin tissue samples showed abundant IRF-5 in the nuclei of these cells (Fig. 2) .
IRF-5 expression during HTLV-1 infection.
To examine whether HTLV-1 infection induces IRF-5 expression, studies were performed using the parental TY8-3 cell line and TY8-3 cells infected with HTLV-1 (TY8-3/MT-2). TY8-3/MT-2 cells strongly expressed Tax mRNA (Fig. 3A) . RT PbMC co-cultured with MMC-treated MT-2 cells expressed Tax mRNA (Fig. 3b) . Furthermore, IRF-5 expression levels increased in these cells following induction of HTLV-1 gene. Noteworthy, IRF-5 expression was still detected in PbMC at 14 days after co-cultivation, which expressed Tax at a very low level (Fig. 3b) . These results indicate that HTLV-1 infection induces the expression of IRF-5 in PbMC as well as T-cell line.
Direct effect of Tax on expression of IRF-5.
Tax gene product is the primary viral transactivator protein that modulates the expression of both viral and cellular genes (17, 18) . To test whether Tax directly induces IRF-5 expression, we used JPx-9, the Jurkat subline carrying Tax under the control of the metallothionein gene promoter (28) . This cell line has been widely used to examine the effect of Tax on the expression of various cellular genes (28) . The results are shown in Fig. 3C . Treatment of JPx-9 with CdCl 2 rapidly induced Tax mRNA expression (panel 1). similarly, Tax protein expression was induced within 24 h after addition of CdCl 2 and reached a maximal level within 120 h (panel 7). Expression of the IRF-5 We also examined the effects of Tax on IRF-5 isoform 3 promoter (P-V3). The activities of the reporter construct containing the entire P-V3 region were analyzed in transient transfection assays in Jurkat cells (Fig. 3D) . Co-transfection of the P-V3 promoter construct in Jurkat cells with Tax expression plasmid enhanced promoter activity in Tax dose-dependent manner. Considered collectively, the above results indicate that Tax can activate IRF-5 P-V3 promoter.
Type I IFN does not regulate IRF-5.
Type I IFN is a wellknown transcriptional inducer of IRF-5 (10). However, its efficacy on IRF-5 induction in T cells is still unknown. Jurkat cells were exposed to IFN-α before RT-PCR. Unexpectedly, IFN-α failed to induce IRF-5 (Fig. 4A) . However, treatment of these cells with IFN-α significantly increased the levels of other IFN-stimulated genes, MxA and 2-5 AS.
IRF-5 targets TNF family cytokine genes.
To assess the potential role of IRF-5 in initiating HTLV-1-infected cell-characteristic gene expression in T cells, Jurkat cells were transfected with control or IRF-5 expression plasmid. After 24 h of transfection, RT-PCR and immunoblotting were performed using specific primers, and anti-IRF-5 and anti-Myc antibodies to confirm transgene expression (Fig. 4B) . In these experiments, changes in IRF-5-induced gene expression were analyzed by microarray analysis. The analysis showed significant enrichment of the up-and downregulated genes in IRF-5-transfected T cells. Table II shows genes that were upregulated by at least 5-fold in the presence of IRF-5. Previous studies reported that HTLV-1 infection induces T-cell activation and in vitro spontaneous lymphocyte proliferation, leading to the production of high levels of TNF-α in non-stimulated PbMC (43) . Typical features of HTLV-1-infected T cells were recapitulated by IRF-5 activity, such as upregulation of TNF-α and LT-β (Table II and Fig. 4b ).
Tax can also induce TNF-α expression. HTLV-1-infected T-cell lines constitutively secrete TNF-α (44). Furthermore, TNF-α expression is activated in the arthritic joints of Tax transgenic mice compared with the normal joints of non-transgenic mice (45) . In the next set of experiments, we examined the effects of Tax on TNF-α expression in T cells. As expected, TNF-α was induced in Tax-expressing JPx-9 (Fig. 5A) . Next, we used several T-cell lines to analyze the role of IRF-5 in the 1-6 ). Western blot analysis was also performed (panels 7-9). (D) Tax also regulates the P-V3 promoter. The P-V3 construct was co-transfected with increasing amounts of expression plasmid for Tax. In all transfection assays the levels of reporter firefly luciferase activity were normalized to a constant level of phRL-TK Renilla luciferase activity that served as an internal control. The results are presented as fold induction of luciferase activity of the P-V3 construct without Tax in Jurkat cells, which was considered 1. Data are mean ± sD of three independent experiments. expression of type I and II IFN, and TNF-α. Compared to control T-cell lines, HTLV-1-infected T-cell lines expressed high levels of TNF-α (Fig. 5b) In the present study, we demonstrated that T cells acquire high levels of IRF-5 expression during HTLV-1 infection. Our results are consistent with those of oligonucleotide microarray reported by baba et al (46) , who identified IRF-5 to be one of the genes that were upregulated more than 40-fold in three HTLV-1-infected T-cell lines, including MT-2, compared with uninfected T-cell line MOLT-4. Our results also showed that the oncoprotein Tax activated the IRF-5 V3 promoter, and that IRF-5 was expressed in ATL cells infiltrating the lymph nodes and skin. Whether the expression of IRF-5 is present in PbMC samples from patients with ATL containing leukemic cells (which do not express Tax protein) was not examined and thus remains a very interesting question. Importantly, ATL-derived MT-1 cells, which also do not express Tax protein, expressed high levels of IRF-5 protein. These results suggest that Tax-independent IRF-5 expression mechanisms may also exist in ATL cells. To establish the effects of endogenous IRF-5 in HTLV-1-infected T cells, we silenced its expression using the siRNA in HUT-102 cells (data not shown). Although IRF-5 silencing was confirmed by RT-PCR and western blot analysis, reduced IRF-5 expression did not affect cell growth (data not shown). In this study, the role of IRF-5 in T cells was investigated using IRF-5-expressing Jurkat cells and cDNA array technology. The results showed that IRF-5 expression does not affect the expression of cell growth-and apoptosis-related genes (data not shown). Furthermore, IRF-5 overexpression did not increase the proliferation of Jurkat cells (data not shown). These studies confirmed that IRF-5 does not directly modulate cell growth. However, the exact IRF-5 function in cell proliferation needs to be further investigated using IRF-5 stable transfectants.
IRF-5 exists in multiple alternatively spliced isoforms that are expressed in a cell type-specific manner (30) . The present results demonstrated that the induction of IRF-5 expression by Tax is isoform-specific. Tax-positive HTLV-1-infected T-cell lines specifically upregulated Ex1V3 transcripts, and the Ex1V3-specific transcripts were upregulated by Tax expression. Indeed, promoter reporter assays demonstrated that Tax enhanced P-V3 promoter activity.
IRF-5 is a central mediator that controls the expression of type I IFN (2). However, there was no link between IRF-5 and type I IFN expression in HTLV-1-infected T cell lines. In addition, IFN-α did not upregulate IRF-5 in Jurkat T cells. Although this finding does not completely exclude IFN-α-induced IRF-5 expression in primary peripheral T cells, the expression of type I IFN seems to be independent of IRF-5 in HTLV-1-infected T cells. On the contrary, IRF-5 expression induced other TNF family genes. TNF-α is a major cytokine involved in the promotion of inflammatory responses, and it plays a crucial role in the pathogenesis of various inflammatory, autoimmune and malignant diseases (47) . Genetic polymorphisms leading to increased TNF-α production enhance susceptibility to not only ATL (48) , but also to uveitis, another HTLV-1-related disease (49) . TNF-α is suggested to contribute to the high levels of organ infiltration by leukemic cells in ATL (50) . Tax can activate mouse TNF-α promoter through nuclear factor-κb (NF-κb) activation (51) . Furthermore, IRF-5 can specifically interact with NF-κb RelA, and sustain TNF-α secretion in human dendritic cells (52) . These findings suggest that Tax/NF-κb/IRF-5 may cooperate in HTLV-1-induced TNF-α promoter activation.
In summary, the present study indicates that high-level IRF-5 expression is specific to HTLV-1-infected T cells. The main function of IRF-5 in ATL and other HTLV-1-related disease should be investigated. 
